Teva CEO says not too late to launch Humira biosimilar in 2024

Teva Pharmaceutical
Industries will still pursue launching a biosimilar of
AbbVie's blockbuster arthritis drug Humira next year
despite a crowded marketplace, Chief Executive Richard Francis
said on...

Related Keywords

New York ,United States ,Jerusalem ,Israel General ,Israel ,Americans ,Patrick Wingrove ,Steven Scheer ,Caroline Humer ,Novarti Sandoz ,Richard Francis ,Teva Pharmaceutical Industries ,Unitedhealth Group Optum ,Boehringer Ingelheim ,Johnson ,Drug Administration ,Cigna Group Express Scripts ,Reuters ,Amgen ,Pharmaceutical Industries ,Chief Executive Richard Francis ,Express Scripts ,Unitedhealth Group ,Bill Berkrot ,Markets ,